Literature DB >> 34999797

Analysis of 3-dimensional interventricular septum and abnormal muscle bundles models for septal myectomy.

Uladzimir Andrushchuk1, Artsem Niavyhlas1, Vitali Adzintsou1, Iryna Haidzel1, Hanna Model1, Aliaksandr Shket1.   

Abstract

OBJECTIVES: We compared the effectiveness of virtual 3-dimensional (3D) models with 2-dimensional (2D) transthoracic echocardiography (TTE) for evaluating the anatomy of the interventricular septum (IVS) and abnormal muscle bundles (AMBs) in planning septal myectomy (SM).
METHODS: Between January 2017 and July 2020, 103 consecutive symptomatic patients with hypertrophic cardiomyopathy underwent 2D TTE and cardiovascular magnetic resonance imaging in 49 (47.6%) or computed tomography angiography in 54 (52.4%) patients with 3D IVS modelling for SM planning. We evaluated maximal IVS thickness and location, length and thickness of AMBs.
RESULTS: The mean maximal IVS thickness by 2D TTE was 7.3 [standard deviation (SD) 4.8] mm less than that based on the 3D model analysis: 21.4 (SD 3.7) vs 28.6 (SD 5.5) mm, respectively (P < 0.001, 95% confidence interval 6.4-8.2). The planned volume of ideal SM was larger than that of performed SM: 26.2 (18.4-39.4) vs 10.3 (7.4-12.8) cm3, respectively (P < 0.001). The sensitivity and specificity of 2D TTE in diagnosing AMBs were 36.9% and 95%, and those of cardiovascular magnetic resonance and computed tomography angiography with 3D modelling were 97.1% and 100% for cardiovascular magnetic resonance and 98% and 100% for computed tomography angiography, respectively. AMBs occurred in 84 (81.6%) patients. No patient required mitral valve replacement. The 30-day mortality was 1 patient. There were 4 late non-cardiac deaths (3.9%) within 18.1 (standard error 1.32) months.
CONCLUSIONS: Anatomical analysis of the IVS and AMBs based on their virtual 3D models is highly effective for SM planning.
© The Author(s) 2021. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  3-Dimensional model; Hypertrophic obstructive cardiomyopathy; Interventricular septum; Septal myectomy

Mesh:

Year:  2021        PMID: 34999797      PMCID: PMC8932507          DOI: 10.1093/icvts/ivab213

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  14 in total

Review 1.  The role of magnetic resonance imaging in hypertrophic cardiomyopathy.

Authors:  Edward T D Hoey; Mohamed Elassaly; Arul Ganeshan; Richard W Watkin; Helen Simpson
Journal:  Quant Imaging Med Surg       Date:  2014-10

2.  Hospital Volume Outcomes After Septal Myectomy and Alcohol Septal Ablation for Treatment of Obstructive Hypertrophic Cardiomyopathy: US Nationwide Inpatient Database, 2003-2011.

Authors:  Luke K Kim; Rajesh V Swaminathan; Patrick Looser; Robert M Minutello; S Chiu Wong; Geoffrey Bergman; Srihari S Naidu; Christopher L F Gade; Konstantinos Charitakis; Harsimran S Singh; Dmitriy N Feldman
Journal:  JAMA Cardiol       Date:  2016-06-01       Impact factor: 14.676

3.  Significance of left ventricular apical-basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.

Authors:  Christiane Gruner; Raymond H Chan; Andrew Crean; Harry Rakowski; Ethan J Rowin; Melanie Care; Djeven Deva; Lynne Williams; Evan Appelbaum; C Michael Gibson; John R Lesser; Tammy S Haas; James E Udelson; Warren J Manning; Katherine Siminovitch; Anthony C Ralph-Edwards; Hassan Rastegar; Barry J Maron; Martin S Maron
Journal:  Eur Heart J       Date:  2014-05-08       Impact factor: 29.983

4.  Virtual and real septal myectomy using 3-dimensional printed models.

Authors:  Uladzimir Andrushchuk; Vitali Adzintsou; Artem Nevyglas; Hanna Model
Journal:  Interact Cardiovasc Thorac Surg       Date:  2018-05-01

5.  Three-dimensional printing in adult cardiovascular medicine for surgical and transcatheter procedural planning, teaching and technological innovation.

Authors:  Enrico Ferrari; Michele Gallo; Changtian Wang; Lei Zhang; Maurizio Taramasso; Francesco Maisano; Luigi Pirelli; Denis Berdajs; Ludwig Karl von Segesser
Journal:  Interact Cardiovasc Thorac Surg       Date:  2020-02-01

6.  Expanding the indications for septal myectomy in patients with hypertrophic cardiomyopathy: results of operation in patients with latent obstruction.

Authors:  Hartzell V Schaff; Joseph A Dearani; Steve R Ommen; Paul Sorajja; Rick A Nishimura
Journal:  J Thorac Cardiovasc Surg       Date:  2011-12-10       Impact factor: 5.209

7.  Transaortic Chordal Cutting: Mitral Valve Repair for Obstructive Hypertrophic Cardiomyopathy With Mild Septal Hypertrophy.

Authors:  Paolo Ferrazzi; Paolo Spirito; Attilio Iacovoni; Alice Calabrese; Katrin Migliorati; Caterina Simon; Samuele Pentiricci; Daniele Poggio; Massimiliano Grillo; Pietro Amigoni; Maria Iascone; Andrea Mortara; Barry J Maron; Michele Senni; Paolo Bruzzi
Journal:  J Am Coll Cardiol       Date:  2015-10-13       Impact factor: 24.094

8.  Extended myectomy for hypertrophic obstructive cardiomyopathy.

Authors:  B J Messmer
Journal:  Ann Thorac Surg       Date:  1994-08       Impact factor: 4.330

Review 9.  Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

Authors:  Martin S Maron
Journal:  J Cardiovasc Magn Reson       Date:  2012-02-01       Impact factor: 5.364

10.  Application of 3D printing in the surgical planning of hypertrophic obstructive cardiomyopathy and physician-patient communication: a preliminary study.

Authors:  Hong-Chang Guo; Yang Wang; Jiang Dai; Chang-Wei Ren; Jin-Hua Li; Yong-Qiang Lai
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.